Subscribe to Newsletter
Subspecialties Glaucoma

A Long Term Look at CLASS

CO2 Laser-Assisted Sclerectomy Surgery (CLASS) is an outpatient procedure that provides significant IOP-lowering efficacy with a safety profile similar to those of manual non-penetrating deep sclerectomy. CLASS is performed through a standard, manually created superficial scleral flap, followed by repeated ablations of the scleral tissue at a depth of approximately 30 µm in a predefined pattern (see Box: The CLASS procedure). This exposes Schlemm’s canal, and facilitates aqueous fluid outflow through the remaining thin trabeculodescemet membrane. Prior to unroofing Schlemm’s canal, the CO2 laser is used to create a reservoir inside the scleral flap window which is intended to reduce the final bleb size and to increase the secondary (subchoroidal) aqueous humor absorption pathway. This means that the bleb created is much less elevated than what trabeculectomy or tube shunt surgery achieves, and helps to mitigate against some of the bleb-related complications associated with trabeculectomy.

It’s worth reviewing how CLASS works. It uses a CO2 laser, which is extremely effective at ablating dry tissue. But the laser energy is also highly absorbed by water and aqueous solutions, which in effect creates a self-regulating mechanism: once the aqueous humor starts to percolate from the remaining thin membrane, it absorbs the laser energy and prevents it penetrating to deeper layers – which explains why the procedure is non-penetrating.

Figure 1. Complication rates in a 5-year clinical trial of CLASS. Other complications included iris incarcerations (8.3%), peripheral anterior synechiae (5.6%), transient superficial clerato keratitis (3.8%), macular edema (0.9%), and perforation by laser (4.6%). AC, anterior chamber.

Figure 2. CLASS’ efficacy over 5 years of follow-up (1). P<0.008 using Bonferroni correction for multiple comparisons.

Figure 3. CLASS procedure’s success rate (IOP ≤18 mmHg at 5 years) (1).

Looking at the long term…

A five-year clinical trial of the long-term effects of CLASS has recently been presented (1). It was a prospective, multicenter trial that involved 111 patients with primary open angle or pseudoexfoliative glaucoma and who had baseline IOPs of over 18 mmHg. Of the 111 patients, 11 were excluded from the efficacy analysis: five because of protocol deviations and six because the operator failed to manually create an adequate scleral flap.

At the conclusion of the study, the CLASS procedure was shown to be relatively safe with few complications (Figure 1), and was successful in lowering IOP and reducing the average number of medications in the vast majority of patients (Figures 2 and 3). There were no intraoperative safety issues noted, and postoperatively, complications were mostly mild and transitory with no sequelae. So far, there have not been any cases of endophthalmitis or blebitis. Scarring at the incision site was reported, although not unexpected; because ablation takes place below the limbus, corneal scarring near the limbus is also possible. Compared with what might be expected after the standard filtration procedures, bleb-related complications (i.e., vascular blebs and late leakage) were virtually nonexistent, and in general, blebs were diffuse with posterior location.

Step 1. Peritomy and superficial scleral flap dissection extending to the clear cornea.

Step 2. A 90% deep scleral reservoir is created by laser ablation at the bottom of the flap.

Step 3. Laser ablation aimed at Schlemm’s canal until percolation is achieved throughout the treatment area.

Step 4. Scleral flap and conjunctiva suturing.

The CLASS procedure.

… and at the limitations

The single-arm nature of this study limited the ability to judge the outcomes in comparison to incisional procedures, but previous studies have suggested that CLASS is similar to trabeculectomy in terms of efficacy, and to manual non-penetrating deep sclerectomy in terms of safety (2). During the first year, the trial was prospective, but after the first year, treating surgeons were given latitude to use their own follow up protocols. This potentially introduced several confounding factors that might complicate analysis of the data. However, the IOP curves from each treatment center were almost identical at the end of five years, which appears to indicate a high degree of predictability and reproducibility. Although patients with treatment-naïve glaucoma (in terms of surgery) were studied in the trial, we do not believe that prior treatment should be a contraindication to performing CLASS. I believe CLASS is therefore a viable, effective and non-penetrating alternative to trabeculectomy in patients with glaucoma.

Noa Geffen is an ophthalmologist at the Department of Ophthalmology, Meir Medical Center, Kfar Saba, and the Ein-Tal Eye Center, Tel Aviv, Israel.

The Laser Quest for a Happy Medium

A User’s Guide to SLT

Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. M. Mimouni, E. Assia, N. Geffen. Five years follow up of CO2 laser assisted sclerectomy surgery (CLASS) in open angle glaucoma patients – a multi-center study report. Presented at the 12th EGS Congress, Prague, Czech Republic, June 2016.
  2. G Greifner et al., “Results of a CO2 laser-assisted deep sclerectomy as compared with conventional deep sclerectomy”, J Glaucoma, 25, e630–e638 (2016). PMID: 25383470.
About the Author
Noa Geffen

Noa Geffen is an ophthalmologist at the Department of Ophthalmology, Meir Medical Center, Kfar Saba, and the Ein-Tal Eye Center, Tel Aviv, Israel.

Related Case Studies
Business & Profession Glaucoma
TrabEx Pro: The Next Level in MIGS

| Contributed by MST

Finding Ocular Surface Inflammation

| Contributed by Quidel

Product Profiles

Access our product directory to see the latest products and services from our industry partners

Here
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: